Show simple item record

dc.contributor.authorLissat, Andrej
dc.contributor.authorJoerschke, Mandy
dc.contributor.authorShinde, Dheeraj A
dc.contributor.authorBraunschweig, Till
dc.contributor.authorMeier, Angelina
dc.contributor.authorMakowska, Anna
dc.contributor.authorBortnick, Rachel
dc.contributor.authorHenneke, Philipp
dc.contributor.authorHerget, Georg
dc.contributor.authorGorr, Thomas A
dc.contributor.authorKontny, Udo
dc.date.accessioned2015-09-01T17:33:01Z
dc.date.available2015-09-01T17:33:01Z
dc.date.issued2015-07-28
dc.identifier.citationBMC Cancer. 2015 Jul 28;15(1):552
dc.identifier.urihttp://dx.doi.org/10.1186/s12885-015-1564-7
dc.identifier.urihttp://hdl.handle.net/10724/31817
dc.description.abstractAbstract Background The prognosis of patients with Ewing sarcoma (ES) has improved over the course of the last decades. However, those patients suffering from metastatic and recurrent ES still have only poor chances of survival and require new therapeutic approaches. Interleukin-6 (IL6) is a pleiotropic cytokine expressed by immune cells and a great variety of cancer cells. It induces inflammatory responses, enhances proliferation and inhibits apoptosis in cancer cells, thereby promoting chemoresistance. Methods We investigated expression of IL6, its receptors and the IL6 signal transduction pathway in ES tumor samples and cell lines applying reverse transcriptase PCR, immunoblot and immunohistochemistry. The impact of IL6 on cell viability and apoptosis in ES cell lines was analyzed by MTT and propidium iodide staining, migration assessed by chorioallantoic membrane (CAM) assay. Results Immunohistochemistry proved IL6 expression in the stroma of ES tumor samples. IL6 receptor subunits IL6R and IL6ST were expressed on the surface of ES cells. Treatment of ES cells with rhIL6 resulted in phosphorylation of STAT3. rhIL6 protected ES cells from serum starvation-induced apoptosis and promoted migration. IL6 blood serum levels were elevated in a subgroup of ES patients with poor prognosis. Conclusions These data suggest that IL6 contributes to ES tumor progression by increasing resistance to apoptosis in conditions of cellular stress, such as serum starvation, and by promotion of metastasis.
dc.titleIL6 secreted by Ewing sarcoma tumor microenvironment confers anti-apoptotic and cell-disseminating paracrine responses in Ewing sarcoma cells
dc.typeJournal Article
dc.date.updated2015-07-29T18:33:34Z
dc.language.rfc3066en
dc.rights.holderLissat et al.


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record